Search filters

List of works by Jessica C Hassel

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

scientific article published on 10 November 2017

An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

scientific article published on 29 July 2020

Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.

scientific article

Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab

scientific article

Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies.

scientific article

Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients.

scientific article published on 13 February 2018

Clinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patients

scientific article published on 01 June 2019

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions

scientific article published on 18 May 2017

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

scientific article published on 13 November 2019

Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

scientific article published on 18 February 2016

First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis

scientific article published on 26 February 2019

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

scientific article published on 30 September 2020

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab

scientific article published on 17 September 2020

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients

scientific article published on 01 October 2020

Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders.

scientific article

Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT

scientific article published on 05 June 2018

Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma

scientific article

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

scientific article

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom - ein Update

scientific article published on 01 June 2020

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

scientific article published on 21 November 2020

Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma

scientific article published on 13 January 2020

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

scientific article published on 16 February 2017

Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma.

scientific article published on 20 December 2017

Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data

scientific article published on 31 October 2018

Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update

scientific article published on 03 June 2020

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

scientific article (publication date: June 2016)

Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

scientific article published on 03 October 2019

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

scientific article

The outcome of ex vivo TIL expansion is highly influenced by spatial heterogeneity of the tumor T-cell repertoire and differences in intrinsic in vitro growth capacity between T-cell clones

scientific article published on 17 April 2020

The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.

scientific article published on 24 February 2018

Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management. ⬇️

scientific article published on 23 May 2019

Paulina is supported by:

About Paulina

Help